| ETCGX | FSMAX | ETCGX / FSMAX | |
| Total Expense Ratio | 2.18 | 0.04 | 6,229% |
| Annual Report Gross Expense Ratio | 2.18 | 0.04 | 6,229% |
| Fund Existence | 16 years | 14 years | - |
| Gain YTD | 8.137 | 13.303 | 61% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.97B | 41B | 7% |
| Annual Yield % from dividends | 0.00 | 0.43 | - |
| Returns for 1 year | 5.34 | 10.55 | 51% |
| Returns for 3 years | 30.13 | 67.63 | 45% |
| Returns for 5 years | -20.77 | 26.24 | -79% |
| Returns for 10 years | 89.23 | 118.30 | 75% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NWHUX | 31.90 | 0.10 | +0.31% |
| Nationwide Bailard Tech & Sci Instl Svc | |||
| AZMCX | 20.01 | 0.05 | +0.25% |
| Virtus NFJ Emerging Markets Value C | |||
| NBRIX | 13.45 | 0.01 | +0.07% |
| Neuberger Real Estate I | |||
| NSGAX | 24.65 | N/A | N/A |
| Columbia Cornerstone Equity A | |||
| SHISX | 65.83 | -0.02 | -0.03% |
| BlackRock Health Sciences Opps Svc | |||